Growdea Technologies Pvt Ltd.
Growdea Technologies: Pioneering AI-driven in silico drug discovery for faster, safer, and more effective therapeutics
Company Description
Growdea Technologies Private Limited (established November 2018 at IIT Delhi) is an AI/ML-driven drug discovery company pioneering the integration of machine learning and physics-based computational algorithms to accelerate therapeutic development. Addressing the pharmaceutical industry’s challenges of high costs, long timelines (10–15 years), and high failure rates (80–90%), Growdea’s flagship platform, Analogue, enables rapid virtual screening, lead optimization, and molecular simulations—cutting early-stage research by 4–5 years and saving $200–400 million.
Guided by co-founder Prof. Anurag Rathore (IIT Delhi) and supported by government-funded initiatives like the ICMR vaccine consortium, Growdea has delivered impactful solutions across academia and pharma, including global clients in Australia and Saudi Arabia. With a dynamic multidisciplinary team, multiple scientific publications, and experimentally validated designs, Growdea continues its mission to empower drug discovery scientists with faster, cost-efficient, and effective computational solutions.
